Streetbeat News

Products Services

ETH-USD

Ethereum co-founder Vitalik Buterin, at the BUIDL Asia conference in Seoul, criticized the current understanding of the Metaverse, describing it as 'poorly defined' and more of a 'brand name than a product'. He emphasized that the Metaverse should not be equated solely with virtual reality but should integrate cryptocurrencies, VR, AI, and more for a truly functional experience. Additionally, Buterin invited Elon Musk to explore desktop Linux as an alternative to Microsoft's OS.

Portfolio Pulse from Mehab Qureshi

March 27, 2024 | 11:00 am

KMB

Kimberly-Clark announces a strategic overhaul aiming for over $3B in gross productivity savings and $500M in working capital savings. The company targets organic net sales growth ahead of market growth and adjusted EPS growth in mid-to-high single digits. Additionally, it commits to a 100% natural forest-free ambition across its product portfolio.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 10:57 am

ESLT

Elbit Systems has been chosen by a European country to upgrade its 155mm howitzer battalions with advanced Digital Fires capabilities. This will include integrating Elbit's C4ISR Artillery Suite, Torch-X Fires application, and E-LynX Software Defined Radio (SDR) radios.

Portfolio Pulse from Charles Gross

March 27, 2024 | 10:54 am

ANIP

ANI Pharmaceuticals, Inc. (ANIP) has launched Levofloxacin Oral Solution, a generic version of Levaquin. The U.S. market for this product is estimated at $7.1 million annually, based on data from IQVIA/IMS Health.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 10:51 am

QS

QuantumScape Corporation (NYSE:QS) has started shipping Alpha-2 prototype battery cells to customers, achieving a significant 2024 goal ahead of schedule. These prototypes are crucial for the development of QuantumScape's first commercial product, QSE-5, and feature improvements such as higher energy density compared to previous prototypes.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 10:47 am

SPIR

Spire Global has entered into an agreement to build and operate satellites for HANCOM InSpace, aiming to expand the capabilities of HANCOM-1 (Sejong-1) and establish Korea's first three-satellite remote sensing image data service constellation.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 10:46 am

BX

MRNA

Blackstone (NYSE:BX) has entered into a collaboration with Moderna, Inc. (NASDAQ:MRNA) to provide up to $750 million in funding for Moderna's flu vaccine development. This partnership aims to support Moderna's ambitious goal to launch multiple vaccine products in the coming years through mRNA medicines. The funding from Blackstone Life Sciences will help advance Moderna's influenza program, with Blackstone eligible for milestones and royalties on successful flu products.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 10:38 am

MRK

Merck's stock price increased following FDA approval for its drug Winrevair (sotatercept) aimed at treating adults with pulmonary arterial hypertension.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 10:33 am

MRNA

Moderna, Inc. (NASDAQ:MRNA) announced significant advancements in its mRNA vaccine pipeline at its fifth Vaccines Day event, including successful clinical readouts for four vaccines targeting respiratory, latent, and other viruses. The company's diverse portfolio addresses major infectious diseases with 28 vaccines in development. Key updates include progress on vaccines for CMV, EBV, HSV-2, VZV, norovirus, COVID-19, RSV, and influenza. Moderna's CMV vaccine candidate, mRNA-1647, is in a pivotal Phase 3 trial, while its EBV vaccine candidates, mRNA-1189 and mRNA-1195, are advancing towards Phase 3 trials. The company also highlighted its ongoing Phase 3 trials for COVID-19, RSV, and flu vaccines, with mRNA-1345 for RSV showing promising efficacy. Moderna estimates the total addressable market for its infectious disease vaccines at $52 billion, with significant commercial opportunities in the coming years. The company's manufacturing innovation and investment in research and development support the commercialization of its pipeline.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 10:32 am

VHC

Samsung has entered into a partnership with VirnetX (VHC) to support the investigation of unidentified aerial phenomena (UAP) at Skinwalker Ranch. This collaboration aims to leverage VirnetX's technology in enhancing the research capabilities at the ranch, known for its mysterious sightings.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 10:30 am